Elacestrant Hydrochloride is the hydrochloride salt form of elacestrant, an orally available, selective estrogen receptor degrader (SERD), with antineoplastic activity. Upon oral administration, elacestrant functions as a SERD, which binds to the estrogen receptor (ER) and induces a conformational change that results in the proteosomal degradation of the receptor. This prevents ER-mediated signaling and inhibits proliferation of ER-expressing cancer cells. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Orserdu (TN) and Elacestrant dihydrochloride. Its PubChem CID is 67479909.
Elacestrant dihydrochloride
| CAS No | 1349723-93-8 |
|---|---|
| Molecular Formula | C30H40Cl2N2O2 |
| Molecular Weight | 531.6 g/mol |
| Synonyms | (6R)-6-[2-[ethyl-[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol;dihydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Elacestrant Hydrochloride is the hydrochloride salt form of elacestrant, an orally available, selective estrogen receptor degrader (SERD), with antineoplastic activity.
The listed CAS number is 1349723-93-8.
The listed molecular formula is C30H40Cl2N2O2.
The listed molecular weight is 531.6 g/mol.
(6R)-6-[2-[ethyl-[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol;dihydrochloride.
The source lists Orserdu (TN) and Elacestrant dihydrochloride.